시장보고서
상품코드
1150064

세계의 염증성 장질환 치료 시장 : 점유율, 규모, 동향, 업계 분석 - 적응증별, 약제 클래스별, 투여 경로별, 유통 채널별, 지역별, 부문 예측(2022-2030년)

Inflammatory Bowel Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Disease indication; By Drug Class Insights; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 114 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 염증성 장질환 치료 시장 규모는 2030년까지 308억 달러에 달할 것으로 예측됩니다.

세계의 염증성 장질환 치료(Inflammatory Bowel Disease Treatment) 시장에 대해 조사했으며, 시장 역학, 부문별 분석, 지역 분석, 기업 개요 등의 정보를 제공하고 있습니다.

목차

제1장 서론

  • 보고서 설명
    • 조사 목적
    • 시장 범위
    • 가정
  • 이해관계자

제2장 주요 요약

  • 시장 하이라이트

제3장 조사 방법

  • 개요
    • 데이터 마이닝
  • 정보 출처
    • 1차 정보
    • 2차 정보

제4장 세계의 염증성 장질환 치료 시장 인사이트

  • 염증성 장질환 치료 - 업계 현황
  • 염증성 장질환 치료 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter's Five Forces 분석
    • 공급 기업의 협상력
    • 신규 참여업체의 위협
    • 구매자의 협상력
    • 대체품의 위협
    • 기존 기업간 경쟁력
  • PESTLE 분석
  • 염증성 장질환 치료 업계 동향
  • 밸류체인 분석
  • COVID-19 영향 분석

제5장 세계의 염증성 장질환 치료 시장 : 적응증별

  • 주요 조사 결과
  • 서론
    • 세계의 염증성 장질환 치료 시장 : 적응증별(2018-2030년)
  • 크론병
    • 세계의 염증성 장질환 치료 시장 : 크론병별, 지역별(2018-2030년)
  • 궤양성 대장염
    • 세계의 염증성 장질환 치료 시장 : 궤양성 대장염별, 지역별(2018-2030년)

제6장 세계의 염증성 장질환 치료 시장 : 약제 클래스별

  • 주요 조사 결과
  • 서론
    • 세계의 염증성 장질환 치료 시장 : 약제 클래스별(2018-2030년)
  • 아미노살리실산염
    • 세계의 염증성 장질환 치료 시장 : 아미노살리실산염별, 지역별(2018-2030년)
  • 코르티코스테로이드
    • 세계의 염증성 장질환 치료 시장 : 코르티코스테로이드별, 지역별(2018-2030년)
  • TNF 억제제
    • 세계의 염증성 장질환 치료 시장 : TNF 억제제별, 지역별(2018-2030년)
  • IL 억제제
    • 세계의 염증성 장질환 치료 시장 : IL 억제제별, 지역별(2018-2030년)
  • 항인테그린제
    • 세계의 염증성 장질환 치료 시장 : 항인테그린제별, 지역별(2018-2030년)
  • JAK 억제제
    • 세계의 염증성 장질환 치료 시장 : JAK 억제제별, 지역별(2018-2030년)
  • 기타
    • 세계의 염증성 장질환 치료 시장 : 기타별, 지역별(2018-2030년)

제7장 세계의 염증성 장질환 치료 시장 : 투여 경로별

  • 주요 조사 결과
  • 서론
    • 세계의 염증성 장질환 치료 시장 : 투여 경로별(2018-2030년)
  • 경구
    • 세계의 염증성 장질환 치료 시장 : 경구별, 지역별(2018-2030년)
  • 주사제
    • 세계의 염증성 장질환 치료 시장 : 주사제별, 지역별(2018-2030년)

제8장 세계의 염증성 장질환 치료 시장 : 유통 채널별

  • 주요 조사 결과
  • 서론
    • 세계의 염증성 장질환 치료 시장 : 유통 채널별(2018-2030년)
  • 병원 약국
    • 세계의 염증성 장질환 치료 시장 : 병원 약국별, 지역별(2018-2030년)
  • 소매 약국
    • 세계의 염증성 장질환 치료 시장 : 소매 약국별, 지역별(2018-2030년)
  • 온라인 약국
    • 세계의 염증성 장질환 치료 시장 : 온라인 약국별, 지역별(2018-2030년)

제9장 세계의 염증성 장질환 치료 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 염증성 장질환 치료 시장 평가 : 지역별(2018-2030년)
  • 북미
    • 적응증별(2018-2030년)
    • 유통 채널별(2018-2030년)
    • 약제 클래스별(2018-2030년)
    • 투여 경로별(2018-2030년)
    • 미국
    • 캐나다
  • 유럽
    • 적응증별(2018-2030년)
    • 유통 채널별(2018-2030년)
    • 약제 클래스별(2018-2030년)
    • 투여 경로별(2018-2030년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
  • 아시아태평양
    • 적응증별(2018-2030년)
    • 유통 채널별(2018-2030년)
    • 약제 클래스별(2018-2030년)
    • 투여 경로별(2018-2030년)
    • 중국
    • 인도
    • 일본
    • 말레이시아
    • 인도네시아
    • 한국
  • 중동 및 아프리카
    • 적응증별(2018-2030년)
    • 유통 채널별(2018-2030년)
    • 약제 클래스별(2018-2030년)
    • 투여 경로별(2018-2030년)
    • 사우디아라비아
    • 남아프리카공화국
    • 이스라엘
    • 아랍에미리트
  • 라틴아메리카
    • 적응증별(2018-2030년)
    • 유통 채널별(2018-2030년)
    • 약제 클래스별(2018-2030년)
    • 투여 경로별(2018-2030년)
    • 멕시코
    • 브라질
    • 아르헨티나

제10장 경쟁 상황

  • 사업 확대와 인수 분석
    • 사업 확대
    • 인수
  • 파트너십/협업/협정/전시회

제11장 기업 개요

  • AbbVie Inc.,
  • Biogen
  • Johnson & Johnson Services, Inc.
  • Amgen Inc.
  • UCB S.A.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Bausch health companies inc.
  • Bristol-myers squibb company
  • Merck & co., inc.
  • Pfizer Inc.
  • Celltrion Inc.
  • Janssen Biotech
  • Allergan plc.
KSM 22.11.25

The global inflammatory bowel disease treatment market size is expected to reach USD 30.80 billion by 2030, according to a new study by Polaris Market Research. The report "Inflammatory Bowel Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Disease indication; By Drug Class; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The industry for enhanced diagnostic and therapy for inflammatory bowel disease is growing as a result of rising cases of IBD in various regions. The frequency of ulcerative colitis and Crohn's disease is on the rise as a result of a number of variables, such as genetic predisposition, environmental triggers, and immune system disruption.

Most people with Crohn's disease or ulcerative colitis have a family history of the disorder. Each year, 70,000 new cases of IBD are identified, and up to 80,000 youngsters may develop ulcerative colitis or Crohn's disease (CD) (UC). According to Hammer et al., IBD is thought to affect 2.5 to 3 million people in Europe or around 0.3% of the overall population. As per British medical journals, IBD could affect up to 240 000 people in the UK.

Increased disease detection rates and adequate reimbursement regulations in industrialized countries aid industry expansion as early disease diagnosis becomes increasingly crucial. As a result, more patients are obtaining treatment for IBD, which has increased demand for drugs, including toll-like receptor agonists, TNF inhibitors, IL inhibitors, JAK inhibitors, and others that are used to treat the condition.

A larger disease burden of IBD, significant improvements in our understanding of disease pathophysiology, and the development of improved diagnostic and therapeutic drugs are among additional variables that contribute to increased diagnosis rates. In addition to the previously mentioned improvements in access to healthcare systems, better diagnostic techniques for detecting UC early in the illness course, and more knowledge among physicians, patients, and healthcare professionals.

Inflammatory Bowel Disease Treatment Market Report Highlights

In 2021, Crohn's disease dominated the IBD market. It is expected that the segment will remain dominant during the forecast period.

The injectable category dominated the market for the treatment of inflammatory bowel disease in 2021 with a revenue share. The segment's dominance is due to the great efficacy of injectable drugs.

The hospital pharmacy industry dominated the market for the treatment of inflammatory bowel disease in 2021, accounting for the largest revenue share. The sector is predicted to dominate the market during the forecasted period.

The industry players with global presence includes AbbVie, Biogen, Johnson & Johnson, Amgen, UCB S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Bausch Health, Bristol-Myers Squibb Company, Gilead sciences, Merck, Pfizer, Lilly, and Celltrion.

Polaris Market Research has segmented the Inflammatory Bowel Disease Treatment market report based on drug class, route of administration, distribution channel, and region:

Inflammatory Bowel Disease Treatment, Type Outlook (Revenue, USD Million, 2018 - 2030)

Crohn's Disease

Ulcerative Colitis

Inflammatory Bowel Disease Treatment, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

Amino salicylates

Corticosteroids

TNF inhibitors

IL inhibitors

Anti-integrin

JAK inhibitors

Others

Inflammatory Bowel Disease Treatment, Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Oral

Injectable

Inflammatory Bowel Disease Treatment, Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Inflammatory Bowel Disease Treatment, Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Inflammatory Bowel Disease Treatment Market Insights

  • 4.1. Inflammatory Bowel Disease Treatment - Industry Snapshot
  • 4.2. Inflammatory Bowel Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising prevalence of Crohn's disease and ulcerative colitis
      • 4.2.1.2. Increasing geriatric population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of early diagnosis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Inflammatory Bowel Disease Treatment Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Inflammatory Bowel Disease Treatment Market, by Disease indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
  • 5.3. Crohn's Disease
    • 5.3.1. Global Inflammatory Bowel Disease Treatment Market, by Crohn's Disease, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Ulcerative Colitis
    • 5.4.1. Global Inflammatory Bowel Disease Treatment Market, by Ulcerative Colitis, by Region, 2018 - 2030 (USD Billion)

6. Global Inflammatory Bowel Disease Treatment Market, by Drug Class Insights

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
  • 6.3. Amino salicylates
    • 6.3.1. Global Inflammatory Bowel Disease Treatment Market, by Amino salicylates, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Corticosteroids
    • 6.4.1. Global Inflammatory Bowel Disease Treatment Market, by Corticosteroids, by Region, 2018 - 2030 (USD Billion)
  • 6.5. TNF inhibitors
    • 6.5.1. Global Inflammatory Bowel Disease Treatment Market, by TNF inhibitors, by Region, 2018 - 2030 (USD Billion)
  • 6.6. IL inhibitors
    • 6.6.1. Global Inflammatory Bowel Disease Treatment Market, by IL inhibitors, by Region, 2018 - 2030 (USD Billion)
  • 6.7. Anti-integrin
    • 6.7.1. Global Inflammatory Bowel Disease Treatment Market, by Anti-integrin, by Region, 2018 - 2030 (USD Billion)
  • 6.8. JAK inhibitors
    • 6.8.1. Global Inflammatory Bowel Disease Treatment Market, by JAK inhibitors, by Region, 2018 - 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Inflammatory Bowel Disease Treatment Market, by Others, by Region, 2018 - 2030 (USD Billion)

7. Global Inflammatory Bowel Disease Treatment Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 7.3. Oral
    • 7.3.1. Global Inflammatory Bowel Disease Treatment Market, by Oral, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Injectable
    • 7.4.1. Global Inflammatory Bowel Disease Treatment Market, by Injectable, by Region, 2018 - 2030 (USD Billion)

8. Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.3. Hospital Pharmacy
    • 8.3.1. Global Inflammatory Bowel Disease Treatment Market, by Hospital Pharmacy, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Retail Pharmacy
    • 8.4.1. Global Inflammatory Bowel Disease Treatment Market, by Retail Pharmacy, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Online Pharmacy
    • 8.5.1. Global Inflammatory Bowel Disease Treatment Market, by Online Pharmacy, by Region, 2018 - 2030 (USD Billion)

9. Global Inflammatory Bowel Disease Treatment Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Inflammatory Bowel Disease Treatment Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Inflammatory Bowel Disease Treatment Market - North America
    • 9.3.1. North America: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.3.5. Inflammatory Bowel Disease Treatment Market - U.S.
      • 9.3.5.1. U.S.: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.3.6. Inflammatory Bowel Disease Treatment Market - Canada
      • 9.3.6.1. Canada: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 9.4. Inflammatory Bowel Disease Treatment Market - Europe
    • 9.4.1. Europe: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.5. Inflammatory Bowel Disease Treatment Market - UK
      • 9.4.5.1. UK: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.6. Inflammatory Bowel Disease Treatment Market - France
      • 9.4.6.1. France: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.7. Inflammatory Bowel Disease Treatment Market - Germany
      • 9.4.7.1. Germany: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.8. Inflammatory Bowel Disease Treatment Market - Italy
      • 9.4.8.1. Italy: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.9. Inflammatory Bowel Disease Treatment Market - Spain
      • 9.4.9.1. Spain: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.10. Inflammatory Bowel Disease Treatment Market - Netherlands
      • 9.4.10.1. Netherlands: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.11. Inflammatory Bowel Disease Treatment Market - Russia
      • 9.4.11.1. Russia: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 9.5. Inflammatory Bowel Disease Treatment Market - Asia Pacific
    • 9.5.1. Asia Pacific: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.5. Inflammatory Bowel Disease Treatment Market - China
      • 9.5.5.1. China: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.6. Inflammatory Bowel Disease Treatment Market - India
      • 9.5.6.1. India: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.7. Inflammatory Bowel Disease Treatment Market - Japan
      • 9.5.7.1. Japan: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.8. Inflammatory Bowel Disease Treatment Market - Malaysia
      • 9.5.8.1. Malaysia: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.9. Inflammatory Bowel Disease Treatment Market - Indonesia
      • 9.5.9.1. Indonesia: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.10. Inflammatory Bowel Disease Treatment Market - South Korea
      • 9.5.10.1. South Korea: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 9.6. Inflammatory Bowel Disease Treatment Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.6.5. Inflammatory Bowel Disease Treatment Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.6.6. Inflammatory Bowel Disease Treatment Market - South Africa
      • 9.6.6.1. South Africa: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.6.7. Inflammatory Bowel Disease Treatment Market - Israel
      • 9.6.7.1. Israel: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.6.8. Inflammatory Bowel Disease Treatment Market - UAE
      • 9.6.8.1. UAE: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 9.7. Inflammatory Bowel Disease Treatment Market - Latin America
    • 9.7.1. Latin America: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.7.5. Inflammatory Bowel Disease Treatment Market - Mexico
      • 9.7.5.1. Mexico: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.7.6. Inflammatory Bowel Disease Treatment Market - Brazil
      • 9.7.6.1. Brazil: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.7.7. Inflammatory Bowel Disease Treatment Market - Argentina
      • 9.7.7.1. Argentina: Inflammatory Bowel Disease Treatment Market, by Disease indication, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Inflammatory Bowel Disease Treatment Market, by Drug Class Insights, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AbbVie Inc.,
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Disease indication Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Biogen
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Disease indication Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Johnson & Johnson Services, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Disease indication Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Amgen Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Disease indication Benchmarking
    • 11.4.4. Recent Development
  • 11.5. UCB S.A.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Disease indication Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Novartis AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Disease indication Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Takeda Pharmaceutical Company Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Disease indication Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Bausch health companies inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Disease indication Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Bristol-myers squibb company
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Disease indication Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Merck & co., inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Disease indication Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Pfizer Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Disease indication Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Celltrion Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Disease indication Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Janssen Biotech
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Disease indication Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Allergan plc.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Disease indication Benchmarking
    • 11.14.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제